JOHNSON JENNIFER M
Transaction: 06/27/2026
BUY
Change
—
Price
Not reported
Filing
06/30/2026
Type
BUY
Thermo Fisher Scientific Inc.
TMO • Medical - Diagnostics & Research
$0.00
— 0.00 (0.00%)
EarningsLatest report: Mar 28, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$186.32B
Growth
8.0%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 15.1%Positive free cash flow · 16.74Consistent free cash flow · 5/5Manageable debt level · 0.76Healthy liquidity · 1.89
Financial data as of: Mar 28, 2026, 12:00 AM UTCLast earnings update: Apr 23, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$186.32B
52W Range403.36 - 643.99
Beta0.87
Gross Margin37.66%
Oper. Margin18.20%
Profit Margin15.12%
Debt/Eq0.76
Current Ratio1.89
Quick Ratio1.53
Revenue 5Y8.01%
Price$0.00
Change0.00%
Market Cap$186.32B
52W Range403.36 - 643.99
Beta0.87
Gross Margin37.66%
Oper. Margin18.20%
Profit Margin15.12%
Debt/Eq0.76
Current Ratio1.89
Quick Ratio1.53
Revenue 5Y8.01%
Target$592.45
Target Median$615.00
Target Range490.00 - 683.00
Volume2.42M
Avg Volume2.30M
EPS Surprise0.19
Investment DNA
How strong this company looks for long-term investors
71
out of 100
Business Quality
Margins, moat, returns
76/100
Financial Strength
Debt, cash, stability
82/100
Growth Potential
Revenue and expansion
44/100
Price Attractiveness
Cheap or expensive today
49/100
Why this score▼
Stable or improving margins · 15.1%Positive free cash flow · 16.74Consistent free cash flow · 5/5Manageable debt level · 0.76Healthy liquidity · 1.89
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-01
Low
$490.00
Mean
$592.45
Median
$615.00
High
$683.00
Insider Transactions
Recent executive and insider activity
Lynch Karen S
Transaction: 06/27/2026
BUY
Change
—
Price
Not reported
Filing
06/30/2026
Type
BUY
WEISLER DION J
Transaction: 06/27/2026
BUY
Change
—
Price
Not reported
Filing
06/30/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| JOHNSON JENNIFER M | BUY | — | Not reported | 06/27/2026 | 06/30/2026 |
| Lynch Karen S | BUY | — | Not reported | 06/27/2026 | 06/30/2026 |
| WEISLER DION J | BUY | — | Not reported | 06/27/2026 | 06/30/2026 |
| Keith R. Alexandra | BUY | — | Not reported | 06/27/2026 | 06/30/2026 |
| SPERLING SCOTT M | BUY | — | Not reported | 06/27/2026 | 06/30/2026 |
| Chai Nelson | BUY | +499 | Not reported | 05/20/2026 | 05/22/2026 |
| CHANDY RUBY R | BUY | +499 | Not reported | 05/20/2026 | 05/22/2026 |
| HARRIS C MARTIN | BUY | +499 | Not reported | 05/20/2026 | 05/22/2026 |
| Jacks Tyler | BUY | +499 | Not reported | 05/20/2026 | 05/22/2026 |
| JOHNSON JENNIFER M | BUY | +499 | Not reported | 05/20/2026 | 05/22/2026 |
| Keith R. Alexandra | BUY | +499 | Not reported | 05/20/2026 | 05/22/2026 |
| Lynch Karen S | BUY | +499 | Not reported | 05/20/2026 | 05/22/2026 |
| Spar Debora L | BUY | +499 | Not reported | 05/20/2026 | 05/22/2026 |
| SPERLING SCOTT M | BUY | +499 | Not reported | 05/20/2026 | 05/22/2026 |
| WEISLER DION J | SELL | — | $451.79 | 05/20/2026 | 05/22/2026 |
| Pettiti Gianluca | SELL | -400 | $462.66 | 04/27/2026 | 04/29/2026 |
| WEISLER DION J | BUY | — | Not reported | 03/28/2026 | 03/31/2026 |
| JOHNSON JENNIFER M | BUY | — | Not reported | 03/28/2026 | 03/31/2026 |
| Lynch Karen S | BUY | — | Not reported | 03/28/2026 | 03/31/2026 |
| Keith R. Alexandra | BUY | — | Not reported | 03/28/2026 | 03/31/2026 |